This notion finds support in the elevated levels of inflammatory markers observed in cancer patients, including C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukins 2, 6, and 8[14], all linked to increased arrhythmic susceptibility. This evidence concerns the gene CRP and cancer.